You are here: Industry Insights > GSK

News List

GSK, Vir expand collaboration for influenza, respiratory virus therapies pharmaceutical-technology
February 18, 2021
GlaxoSmithKline (GSK) has signed a binding agreement with Vir Biotechnology to expand its existing partnership to research and develop novel therapies for influenza and other respiratory viruses.
ViiV’s Rukobia receives marketing authorisation in Europe for HIV treatment pharmaceutical-technology
February 10, 2021
GlaxoSmithKline’s (GSK) ViiV Healthcare has announced the European Marketing Authorisation of its Rukobia (fostemsavir) 600mg extended-release tablets for use in combination with antiretroviral (ARV) therapies for treating adults with ...
NICE green light for GSK's Nucala pharmatimes
February 05, 2021
GlaxoSmithKline's Nucala (mepolizumab) will be funded on the NHS in England and Wales for treating patients with severe eosinophilic asthma.
GSK, CureVac Enter New €150M COVID Vax Pact contractpharma
February 04, 2021
GSK will support the manufacture of up to 100 million doses of CureVac’s first generation COVID-19 vaccine candidate CVnCoV in 2021.
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet prnasia
February 01, 2021
Clover Biopharmaceuticals today announced that the data from its Phase 1 clinical trial evaluating the safety and immunogenicity of its protein-based adjuvanted S-Trimer COVID-19 vaccine candidates was published in the peer-reviewed journal, The Lancet.
Lilly, Vir and GSK collaborate for trial of Covid-19 therapies pharmaceutical-technology
January 28, 2021
Eli Lilly and Company, Vir Biotechnology, and GlaxoSmithKline (GSK) have entered into a partnership to analyse a combination of two therapies in low-risk patients with mild to moderate Covid-19.
GSK, PATH, Bharat Biotech sign product transfer agreement for malaria vaccine expresspharma
January 28, 2021
Transfer builds on commitments to donate up to 10 million vaccine doses to the pilot implementation in regions of Ghana, Kenya, and Malawi and supply up to 15 million doses annually to 2028 if recommended for wider use.
Pharma companies move towards systematic access planning approaches: 2021 Access to Medicine Index expresspharma
January 27, 2021
A new shift in pharma company policy could shorten the time people in lower-income countries must typically wait for new medicines and vaccines, reports the 2021 Access to Medicine Index.
Hikma intends to acquire assets in Egypt, Tunisia expresspharma
January 27, 2021
Hikma Pharmaceuticals said it was planning to buy GSK’s stake in some assets including the drugmaker’s pharma, consumer commercialisation and manufacturing business in Egypt and its drugs business in Tunisia.
Novartis, GSK team up for $3.6m genetic diversity research in Africa pharmaceutical-business-review
January 22, 2021
Swiss pharma giant Novartis and British pharmaceuticals company GSK have teamed up to conduct scientific research linking genetic diversity in Africa and its potential impact on response to drug therapeutics.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page